Difference between revisions of "Tagraxofusp (Elzonris)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= Diphtheria toxin conjugated to interleukin 3 =Preliminary studies= # Frankel AE, Woo JH, Ahn C, Pemmaraju N, Medeiros BC, Carraway HE, Frankfurt O, Form...") |
m (Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm") |
||
| Line 3: | Line 3: | ||
=Preliminary studies= | =Preliminary studies= | ||
| − | # Frankel AE, Woo JH, Ahn C, Pemmaraju N, Medeiros BC, Carraway HE, Frankfurt O, Forman SJ, Yang XA, Konopleva M, Garnache-Ottou F, Angelot-Delettre F, Brooks C, Szarek M, Rowinsky E. Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood. 2014 Jul 17;124(3):385-92. Epub 2014 May 23. [http://www.bloodjournal.org/content/124/3/385.long link to original article] [ | + | # Frankel AE, Woo JH, Ahn C, Pemmaraju N, Medeiros BC, Carraway HE, Frankfurt O, Forman SJ, Yang XA, Konopleva M, Garnache-Ottou F, Angelot-Delettre F, Brooks C, Szarek M, Rowinsky E. Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood. 2014 Jul 17;124(3):385-92. Epub 2014 May 23. [http://www.bloodjournal.org/content/124/3/385.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24859366 PubMed] |
[[Category:Investigational]] | [[Category:Investigational]] | ||
Revision as of 03:11, 2 December 2016
Mechanism of action
Diphtheria toxin conjugated to interleukin 3
Preliminary studies
- Frankel AE, Woo JH, Ahn C, Pemmaraju N, Medeiros BC, Carraway HE, Frankfurt O, Forman SJ, Yang XA, Konopleva M, Garnache-Ottou F, Angelot-Delettre F, Brooks C, Szarek M, Rowinsky E. Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood. 2014 Jul 17;124(3):385-92. Epub 2014 May 23. link to original article PubMed